Insights on Managing Cough Symptoms in Patients With IPF

Steven Nathan, MD, discusses how the findings from the study on oral nalbuphine extended release suggest that this treatment may offer an effective option for managing IPF-related cough, providing significant relief in terms of both frequency and severity, which could shift current management strategies by introducing a more targeted, pharmacologic approach to addressing one of the most challenging symptoms of IPF.

EP: 1.CHEST 2024: Updates in IPF and PAH Care

EP: 2.Key Predictors of Survival in IPF: Findings From the IPF-PRO Registry

EP: 3.Implications of IPF Survival Data for Clinical Practice and Early Intervention

EP: 4.Evaluating Cough Relief With Oral Nalbuphine in Patients With IPF

Now Viewing

EP: 5.Insights on Managing Cough Symptoms in Patients With IPF

1. What are your key takeaways from this study, and how might these findings impact the way IPF cough symptoms are currently managed?

Related Videos